A cystine capacity test estimates whether urine is likely to dissolve cystine or allow cystine crystals to grow. It is designed for people with cystinuria, an inherited disorder that causes unusually high urinary cystine and recurrent cystine kidney stones. Unlike a simple urine cystine concentration, cystine capacity reflects the overall balance between cystine amount, urine volume, pH, and the effects of cystine-binding thiol drugs such as tiopronin or D-penicillamine. Results are generally expressed so that a positive capacity means the urine is undersaturated and can dissolve additional cystine, while a negative capacity means the urine is supersaturated and favors cystine precipitation. This makes the test especially useful when treatment changes the chemical form of cystine and makes routine cystine measurements harder to interpret. Capacity is not the only monitoring tool; clinicians also follow urine pH, 24-hour volume, sodium, cystine excretion, kidney function, imaging, and stone events.
- Positive cystine capacity generally indicates safer, undersaturated urine, while a negative value indicates urine that can promote cystine crystal growth.
- The test is most useful for monitoring known cystinuria, especially when cystine-binding thiol drugs make routine cystine concentration less reliable.
- Urine volume and pH remain major treatment targets; adult cystinuria care often aims for more than 3 L of urine per day and urine pH above about 7.0–7.5, depending on the treatment plan.
- A single capacity result should not be interpreted alone because collection accuracy, treatment adherence, sodium intake, pH, and medication timing all affect the urine environment.
- Persistent negative capacity despite treatment can prompt changes in fluids, alkalinization, sodium intake, or thiol-drug therapy under specialist supervision.
Table of Contents
- What the Cystine Capacity Test Measures
- What Positive and Negative Cystine Capacity Mean
- Cystine Capacity vs. Urine Cystine Level
- Who May Need Cystine Capacity Testing
- Collection, Accuracy, and Interpretation
- How the Test Guides Cystinuria Treatment
- Limitations, Follow-Up, and When to Seek Care
What the Cystine Capacity Test Measures
Cystine capacity measures the remaining ability of urine to hold cystine in solution. The concept is different from simply counting how many milligrams of cystine are present.
Cystine is poorly soluble in urine. In cystinuria, mutations affecting amino acid transport in the kidney cause large amounts of cystine to spill into urine. When the urine contains more cystine than it can keep dissolved, cystine precipitates into characteristic crystals and can grow into stones.
The capacity assay is a solid-phase test. A known amount of cystine crystal is added to the urine sample and allowed to equilibrate. If the urine is already supersaturated, additional cystine leaves the liquid and deposits onto the added crystals. If the urine is undersaturated, some of the added cystine dissolves into the urine.
That behavior is converted into a numeric capacity result. The result therefore reflects the chemical direction in which the urine wants to move: toward crystal growth or toward crystal dissolution.
This approach is valuable because cystine crystallization is governed by more than excretion alone. Two people can excrete similar total cystine but have very different risks if one has twice the urine volume or a substantially higher urine pH. Capacity folds those influences into one functional measurement. It does not identify which factor is responsible, so the detailed 24-hour urine values still need to be reviewed alongside it.
The assay was developed to address a practical monitoring problem in treated cystinuria. When thiol drugs bind cystine, some standard chemical methods can count mixed disulfide compounds in ways that make the reported concentration difficult to translate into true free-cystine saturation. Measuring whether solid cystine grows or dissolves provides a different type of answer: it directly tests the urine’s ability to support or oppose crystal formation under standardized laboratory conditions.
This test is usually part of a broader cystine stone evaluation. A complete assessment can include 24-hour urine cystine, volume, pH, sodium, creatinine, calcium, citrate, kidney function, stone analysis, imaging, and clinical history.
The test should not be confused with a qualitative screening test such as the cyanide-nitroprusside test, which can show whether excessive cystine is present but does not quantify treatment success. It is also different from genetic testing, which can confirm variants in genes associated with cystinuria but does not directly show whether the urine is currently safe from crystallization.
What Positive and Negative Cystine Capacity Mean
The simplest interpretation is directional: positive is favorable; negative is unfavorable.
A positive cystine capacity means the urine is undersaturated with cystine under the assay conditions. In practical terms, the urine has room to dissolve more cystine before crystal growth becomes favored. A more positive value generally represents a safer chemical environment than a value near zero.
A negative cystine capacity means the urine is supersaturated. Cystine tends to leave solution and deposit on crystals, which is the direction that promotes stone growth. A more negative value generally means greater supersaturation.
Zero is the conceptual balance point between those states. However, cystinuria management should not chase one number without considering the whole picture. A value close to zero may fluctuate from collection to collection depending on fluid intake, urine pH, sodium intake, missed medication, and whether the 24-hour collection was complete.
Unlike many common blood tests, there is not a single universal “normal range” for cystine capacity that applies to everyone. Laboratories may use different reporting conventions, and treatment goals are individualized. The most useful questions are whether the capacity is positive or negative, how far it is from zero, and whether it improves after a treatment change.
A trend can be more informative than one isolated result. For example, a shift from strongly negative to slightly negative may indicate a meaningful response even if the target has not yet been reached. A shift from positive to negative can signal reduced fluid intake, a fall in urine pH, higher sodium exposure, missed medication, or another change that deserves review.
Cystine Capacity vs. Urine Cystine Level
A standard 24-hour urine cystine test measures how much cystine is excreted. It is essential for diagnosis and can be useful during follow-up, but it does not always tell the full story about crystallization.
Cystine solubility changes substantially with urine pH. As urine becomes more alkaline, cystine becomes more soluble. The same total cystine excretion can therefore produce very different stone risk at pH 6.0 and pH 7.5. Urine volume changes concentration as well: 800 mg of cystine distributed through 4 L of urine is chemically different from the same amount in 1.5 L.
Cystine-binding thiol drugs create another problem. Tiopronin and D-penicillamine react with cystine to form more soluble mixed disulfides. Some routine assays cannot cleanly distinguish free cystine from drug-related compounds, so measured “cystine” may not accurately represent the fraction that can crystallize.
Cystine capacity was developed in part to work around this limitation. Instead of asking only how much cystine-like material is measured, it asks whether the urine as a whole can dissolve or deposit cystine. Research has shown that the assay can detect improved cystine solubility during cystine-binding thiol treatment.
That does not make routine cystine measurement obsolete. A urine cystine test remains important for diagnosis and can help quantify disease burden. Capacity adds functional information, especially during therapy.
| Test | Main question | Best use |
|---|---|---|
| 24-hour urine cystine | How much cystine is excreted? | Diagnosis and baseline disease assessment |
| Cystine capacity | Will the urine dissolve or precipitate cystine? | Treatment monitoring, especially on thiol drugs |
| Urine pH | Is the urine alkaline enough to improve cystine solubility? | Daily alkalinization adjustment |
| Urine volume | Is cystine sufficiently diluted? | Hydration target |
| Stone analysis | Is the stone actually cystine? | Confirming stone type |
Who May Need Cystine Capacity Testing
Cystine capacity testing is not a general kidney stone screening test. It is mainly intended for people with known or strongly suspected cystinuria.
Cystinuria often presents earlier in life than common calcium stone disease. Recurrent stones in childhood, adolescence, or early adulthood; a family history of cystine stones; characteristic hexagonal cystine crystals; or a stone analysis showing cystine can trigger a focused evaluation.
Once cystinuria is diagnosed, capacity testing may be useful when:
- stones continue despite high fluid intake and urine alkalinization;
- a cystine-binding thiol drug is started or adjusted;
- routine cystine measurements are difficult to interpret during thiol therapy;
- the clinician wants an objective measure of urine supersaturation response;
- a patient has recurrent stone growth despite apparently acceptable urine pH;
- treatment adherence or adequacy is uncertain.
A cystine capacity result should never replace imaging or clinical follow-up. A positive result does not prove that existing stones have disappeared, and a negative result does not show where a stone is located or whether it is obstructing urine flow.
All cystine stone formers are considered high risk for recurrence. Long-term monitoring is therefore more intensive than for many first-time calcium stone formers. Follow-up commonly includes urine testing, kidney function, blood pressure, medication safety tests when thiol drugs are used, and periodic imaging.
Collection, Accuracy, and Interpretation
Cystine capacity is usually measured from a 24-hour urine collection. Accurate timing and complete collection matter because missed urine changes the measured chemistry and can make the result unrepresentative.
During the collection, follow the laboratory kit instructions exactly. Some tests require specific containers or preservatives. Do not assume that instructions from a previous 24-hour urine test are identical.
For routine treatment monitoring, clinicians generally want the collection to represent a normal treatment day. That means taking prescribed medication as directed, following the usual diet, and drinking the usual intended amount rather than temporarily changing habits to make the result look better.
Important variables to review with the capacity result include:
- Urine volume: low volume raises cystine concentration even if total excretion is unchanged.
- Urine pH: cystine solubility rises as pH increases, so inadequate alkalinization can drive a negative capacity.
- Urine sodium: high sodium intake tends to increase cystine excretion and can undermine treatment.
- Creatinine: helps assess whether the collection was reasonably complete.
- Medication use: missed alkali or thiol doses can worsen capacity.
- Stone activity: new stones or stone growth may show that the biochemical targets are not sufficient for that individual.
Because cystinuria is chronic, one collection should be viewed as a sample of a longer pattern. Hot weather, exercise, travel, gastrointestinal illness, fasting, or unusual diet can temporarily change urine volume and pH. If a surprising result does not fit the usual routine, repeating the test may be appropriate.
When a capacity result worsens, a simple troubleshooting sequence can be useful. First, confirm that the collection was complete. Next, compare urine volume with the usual target and check whether a hot day, heavy exercise, or missed overnight fluids reduced output. Then review pH measurements and alkali dosing, followed by sodium intake and adherence to thiol medication if prescribed. A negative capacity caused by 1.8 L of urine may need a very different response from a negative capacity despite 4 L of urine, good pH, and reliable medication use.
Home urine pH logs can add context because a 24-hour average may hide long periods of low pH. Some patients have acceptable daytime pH but drop overnight, when they are not drinking and the urine becomes more concentrated. Clinicians may adjust the timing of fluids or alkali to address that pattern rather than simply increasing the total daily dose.
How the Test Guides Cystinuria Treatment
Cystinuria treatment aims to keep cystine dissolved. The usual strategy is stepwise: very high fluid intake, lower sodium intake, urinary alkalinization, and cystine-binding thiol medication when simpler measures are not enough.
Fluid is foundational. Current European guidance advises enough intake to produce more than 3 L of urine per day in adults with cystinuria. That often requires drinking throughout the day and evening because long overnight periods without fluid can allow cystine concentration to rise.
Urine alkalinization is the next major lever. Potassium citrate is commonly used to raise urine pH, with many guidelines targeting pH above 7.0 and European guidance commonly aiming above 7.5 for cystine stone prevention. The exact target should be individualized because excessive alkalinization may increase calcium phosphate crystallization.
Sodium restriction can reduce cystine excretion. European guidance advises avoiding sodium intake above about 2 g/day, equivalent to roughly 5 g of salt, although individual nutrition plans may differ.
If stones recur despite these measures, tiopronin or D-penicillamine may be prescribed. These thiol drugs split cystine disulfide bonds and form more soluble compounds. They can be effective but require monitoring because adverse effects may include proteinuria, blood count abnormalities, liver effects, skin reactions, or other toxicity depending on the drug.
Cystine capacity can help determine whether these interventions are moving the urine toward undersaturation. A persistently negative value may lead the clinician to check whether the urine volume is truly high enough, whether pH is maintained throughout the day, whether sodium intake is high, or whether thiol-drug dosing needs adjustment.
Capacity can also help avoid unnecessary escalation. If a patient has a clearly positive value, excellent urine volume, stable imaging, and no new stones, increasing a thiol dose solely because a conventional cystine concentration appears high may not be helpful. Decisions still depend on the full clinical picture, but the assay can provide an additional check on whether the urine is actually supersaturated. This is especially relevant because thiol drugs can cause adverse effects and are generally used at the lowest effective dose that controls stone activity.
A more positive capacity after treatment is encouraging, but it is not the only goal. Imaging should show fewer new stones or less growth, and treatment must remain tolerable enough for long-term adherence. Cystinuria therapy is lifelong, so a theoretically perfect regimen that cannot be sustained may be less effective than a slightly less aggressive plan that is followed consistently.
Limitations, Follow-Up, and When to Seek Care
Cystine capacity is a specialized functional assay, and availability varies. It is not as widely standardized as routine electrolytes or creatinine. Results should therefore be interpreted using the reporting laboratory’s method and the patient’s previous results from the same system when possible.
Evidence supporting capacity is clinically useful but less extensive than the evidence base for common stone tests. Cystinuria is rare, and randomized trials are limited. Current recommendations rely on physiology, observational studies, consensus guidance, and specialist experience.
The test also cannot replace stone imaging, infection evaluation, or kidney function monitoring. A person can have a favorable urine sample and still have an existing obstructing stone. Conversely, an unfavorable capacity does not mean an emergency is occurring; it means the chemical environment favors cystine crystallization and prevention should be reviewed.
Repeat testing is commonly performed after treatment changes and then periodically once stable. Recent cystinuria references describe 24-hour urine monitoring every few months during active adjustment and every 6–12 months when stable, although exact schedules vary.
Seek urgent medical care for stone symptoms with fever or chills, inability to urinate, persistent vomiting, severe uncontrolled pain, a single functioning kidney, or signs of serious illness. An infected obstructed kidney requires urgent treatment and cannot be managed by changing fluid or citrate intake at home.
The most useful way to think about cystine capacity is as a treatment-response gauge. It tells whether the current combination of dilution, alkalinization, diet, and medication is making urine chemically hostile or favorable to cystine stone growth.
References
- Cystinuria: Diagnosis, Medical and Surgical Management, and Emerging Therapies. A Narrative Review. 2026 (Review)
- Metabolic Evaluation and Recurrence Prevention – EAU Guidelines on Urolithiasis – Uroweb 2026 (Guideline)
- Cystinuria 2025 (Review)
- A Summary of Current Guidelines and Future Directions for Medical Management and Monitoring of Patients with Cystinuria. 2023 (Review)
- Pharmacological interventions for the management of cystinuria: a systematic review 2023 (Systematic Review)
- Cystinuria: an update on pathophysiology, genetics, and clinical management 2022 (Review)
Disclaimer
This article is for general education and does not replace care from a clinician experienced in cystinuria. Cystine capacity methods, urine pH targets, drug doses, and monitoring schedules vary by laboratory and patient factors. Do not change potassium citrate, tiopronin, D-penicillamine, or fluid and electrolyte treatment without individualized medical guidance.
